During the past decade, Shanxi Dayi Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanxi Dayi Hospital" #1 sponsor was "Beijing Doing Biomedical Co., Ltd." with 1 trials, followed by "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials sponsored, "Shanxi Dayi Hospital" with 1 trials sponsored, "Si Tianmei" with 1 trials sponsored and "SuperSonic Imagine" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanxi Dayi Hospital" #1 collaborator was "307 Hospital of PLA" with 1 trials as a collaborator, "First Hospital of China Medical University" with 1 trials as a collaborator, "Guangdong Provincial People's Hospital" with 1 trials as a collaborator, "Hebei Medical University Fourth Hospital" with 1 trials as a collaborator and "Hebei Yanda Ludaopei Hospital" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Shanxi Dayi Hospital" are "Breast Neoplasms" (1 trials), "Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type" (1 trials), "Leukemia" (1 trials), "Lymphoma" (1 trials) and "Major Depression Disorder" (1 trials). Many other conditions were trialed in "Shanxi Dayi Hospital" in a lesser frequency.

Most popular intervention types in "Shanxi Dayi Hospital" are "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-CD19-CAR" (1 trials), "Buspirone" (1 trials), "IPGDP regimen chemotherapy" (1 trials), "Medical education" (1 trials) and "Paroxetine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shanxi Dayi Hospital" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Shanxi Dayi Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Shanxi Dayi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shanxi Dayi Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".